Point of Care (POC) Molecular Diagnostics Global Strategic Research Report 2024: Market to Reach $8.8 Billion by 2030 - Emphasis on Decentralized Diagnostics Presents Opportunities [Yahoo!...
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
- Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Point of Care (POC) Molecular Diagnostics Market to Reach $8.8 Billion by 2030 The global market for Point of Care (POC) Molecular Diagnostics estimated at US$3.7 Billion in the year 2023, is projected to reach a revised size of US$8.8 Billion by 2030, growing at a CAGR of 11.4% over the analysis period 2023-2030. The provided information sheds light on the point of care (POC) molecular diagnostics industry, a field leveraging molecular technologies to monitor human diseases. It outlines the various types of molecular diagnostics tests and introduces the concept of POC molecular diagnostics, highlighting its significance in healthcare. The document elaborates on the molecular testing mechanisms and compares molecular and non-molecular POC testing methods. It also offers insights into the global market prospects and outlook for POC molecular diagnostics, emphasizing PCR techno
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Anatomic Pathology Market is Poised to Reach USD 71.52 Billion By 2032: Astute Analytica [Yahoo! Finance]Yahoo! Finance
- Danaher Corporation: A Good Medium Term Bet [Seeking Alpha]Seeking Alpha
- Anti-Mullerian Hormone Test Market Projected to Reach $586.48 million by 2030 - Exclusive Report by 360iResearch [Yahoo! Finance]Yahoo! Finance
- Oligonucleotide Synthesis Market Worth $19.7 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power [Yahoo! Finance]Yahoo! Finance
DHR
Earnings
- 4/23/24 - Beat
DHR
Sec Filings
- 4/29/24 - Form 4
- 4/29/24 - Form 4
- 4/29/24 - Form 4
- DHR's page on the SEC website